Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES
Firm Income Reported for This Client
$430K
Not substituted for client expenses
Summary
THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES is an organization, based in DC. Its political footprint includes $430K in lobbying-firm income reported for this client. Lobbying activity focuses on Budget/Appropriations, Medical/Disease Research/Clinical Labs. Political activity spans from 2021 to 2026.